metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Influencia de adyuvantes en la capacidad de los anticuerpos anti-Tbps de bloquea...
Información de la revista
Vol. 20. Núm. 7.
Páginas 316-320 (agosto 2002)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 20. Núm. 7.
Páginas 316-320 (agosto 2002)
Acceso a texto completo
Influencia de adyuvantes en la capacidad de los anticuerpos anti-Tbps de bloquear la unión de transferrina, la asimilación de hierro y el crecimiento en Neisseria meningitidis
Influence of adjuvants on the ability of anti-Tbp antibodies to block transferrin binding, iron uptake and growth of Neisseria meningitidis
Visitas
5595
Carlos Ferreirós1
Autor para correspondencia
mpcfytc@usc.es

Prof. C. Ferreirós. Departamento de Microbiología. Facultad de Farmacia. Universidad de Santiago de Compostela. 15782 La Coruña. España.
, Nuria Ferreiro, M.T. Criado
Departamento de Microbiología. Facultad de Farmacia. Universidad de Santiago de Compostela. La Coruña. España
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Objetivo

Analizar el efecto de cinco adyuvantes en la capacidad de los sueros anti-TbpA/B para bloquear la asimilación de hierro en Neisseria meningitidis. MATERIAL Y MÉTODOS. Se han ensayado 5 formulaciones de adyuvantes para obtener, en ratones, sueros específicos contra los complejos proteicos de unión de transferrina (TbpA/B) purificados de una cepa de N. meningitidis y analizar la influencia del adyuvante en la capacidad de los anticuerpos generados de bloquear la unión de transferrina y, en consecuencia, la asimilación de hierro y el crecimiento de los meningococos.

Resultados

Todos los sueros fueron capaces de inhibir de manera significativa la unión de transferrina, la consiguiente asimilación de hierro y el crecimiento en la cepa homóloga, aunque se observó un claro incremento en los títulos de anticuerpos cuando se emplea RAS como adyuvante (1/3.125 frente a 1/125 con los otros adyuvantes). El efecto de estos sueros en una cepa heteróloga, con una TbpB de isotipo diferente al de la cepa inmunizante, fue casi nulo, lo que concuerda con la división descrita para el meningococo en 2 grupos en función de la TbpB que posean (isotipos I y II).

Conclusiones

Contrariamente a lo ya demostrado para otra importante proteína meningocócica (FbpA), el uso de diferentes adyuvantes en la inmunización de ratones con los complejos TbpA/B no ofrece diferencias en la respuesta inmunitaria producida, excepto en lo relativo al título de anticuerpos.

Palabras clave:
Adyuvantes
Neisseria meningitidis
Proteínas de unión a transferrina
Objective

To evaluate the effect of five adjuvants on the ability of specific anti-TbpA/B to block iron uptake in Neisseria meningitidis.

Material And Methods

Transferrin binding complexes (TbpA/B) purified froma TbpB isotype II Neisseria meningitidis strain were used to obtain sera with fivedifferent adjuvant formulations in mice in order to test the effect of the adjuvant on the ability of specific anti-TbpA/B antibodies to block transferrin binding, iron uptake and growth by meningococci.

Results

Levels of anti-TbpA/B antibodies were relatively low (1:125 in most cases), the highest being obtained with the RAS adjuvant (1:3125). Despite the relatively low responses, all sera were able to significantly inhibit transferrin binding, iron uptake and growth in the homologous strain. Nevertheless, the effect on a strain with a TbpB isotype different from that of the immunizing strain was almost nil, a result in keeping with the described division of the meningococci into at least two TbpB groups (isotypes I and II).

Conclusions

In contrast to previous results for another important meningococcal protein, FbpA, the use of various adjuvants in the immunization of mice with TbpA/B complexes did not produce differences in the immune responses elicited, except in relation to antibody titers.

Key words:
Adjuvants
Neisseria meningitidis
Transferrin-binding proteins
El Texto completo está disponible en PDF
Bibliografía
[1.]
M.E. Ramsay, N. Andrews, E.B. Kaczmarski, E. Miller.
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England.
[2.]
A.B. Schryvers, L.J. Morris.
Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis.
Infect Immun, 56 (1988), pp. 1144-1149
[3.]
A.B. Schryvers, B.C. Lee.
Comparative analysis of the transferrin and lactoferrin binding proteins in the family Neisseriaceae.
Can J Microbiol, 35 (1989), pp. 409-415
[4.]
L. Ferrón, C.M. Ferreirós, M.T. Criado, M.P. Andrade.
Purification of the Neisseria meningitidis transferrin binding protein-2 (Tbp2) to homogeneity using column chromatography.
FEMS Microbiol Lett, 109 (1993), pp. 159-166
[5.]
A. Pettersson, V. Klarenbeek, J. Van Deurzen, J.T. Poolman, J. Tommassen.
Molecular characterization of the structural gene for the lactofferin receptor of the meningococcal strain H44/76.
Microb Pathog, 17 (1994), pp. 395-408
[6.]
L. Lissolo, G. Maitre-Wilmotte, P. Dumas, M. Mignon, B. Danve, M.J. Quentin-Millet.
Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines.
Infect Immun, 63 (1995), pp. 884-890
[7.]
M. Pintor, L. Ferron, J.A. Gomez, A. Gorringe, M.T. Criado, C.M. Ferreiros.
Blocking of iron uptake by monoclonal antibodies specfic for the Neisseria meningitidis transferrin-binding protein 2.
J Med Microbiol, 45 (1996), pp. 252-257
[8.]
M. Pintor, L. Ferron, J.A. Gomez, N.B.L. Powell, D.A.A. Ala’Aldeen, S.P. Borriello.
Blocking of iron uptake from transferrin by antibodies against the transferrin binding proteins in Neisseria meningitidis.
Microb Pathog, 20 (1996), pp. 127-139
[9.]
S.A. Morse, L. Bartenstein.
Purine metabolism in Neisseria gonorrhoeae: the requeriment for hypoxanthine.
Can J Microbiol, 26 (1980), pp. 13-20
[10.]
M. Pintor, C.M. Ferreiros, M.T. Criado.
Characterization of the transferrin-iron uptake system in Neisseria meningitidis.
FEMS Microbiol Lett, 12 (1993), pp. 150-166
[11.]
J.A. Gomez, M.T. Criado, C.M. Ferreiros.
Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37 kDa ferric binding protein (FbpA) with different adjuvants.
FEMS Immunol Med Microbiol, 20 (1998), pp. 79-86
[12.]
M. Pintor, C.M. Ferreirós, M.T. Criado.
Energy-independent binding of iron complexed to samll organic chelants by Neisseria meningitidis.
J Gen Appl Microbiol, 40 (1994), pp. 23-24
[13.]
M. Pintor, C.M. Ferreiros, M.T. Criado, L. Ferron.
Expression levels of human transferrin receptors in Neisseria species.
J Microbiol Meth, 15 (1992), pp. 321-326
[14.]
C. Simonson, D. Brener, I.W. DeVoe.
Expression of a high-affinity mechanisms for acquisition of transferrin iron by Neisseria meningitidis.
Infect Immun, 36 (1982), pp. 159-166
[15.]
R.R. Sokal, F.J. Rohlf.
Single-classification abalysis of variance.
Biometry, 3.aed, pp. 207-211
[16.]
D.A.A. A’Aldeen, S.P. Borriello.
The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains.
Vaccine, 14 (1996), pp. 49-53
[17.]
L. Ferron, C.M. Ferreiros, M.T. Criado, M. Pintor.
Reliability of laboratory models in the analysis of TbpB and other meningococcal antigens.
FEMS Immunol Med Microbiol, 9 (1994), pp. 299-306
[18.]
B. Rokbi, V. Mazarin, G. Maitre-Wilmotte, M.J. Quentin-Millet.
Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features.
FEMS Microbiol Lett, 110 (1993), pp. 51-58
[19.]
L. Ferron, C.M. Ferreiros, M.T. Criado, M. Pintor.
Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis.
Infect Immun, 60 (1992), pp. 2887-2892
[20.]
D.A.A. Ala’Aldeen, P. Stevenson, E. Griffiths, A.R. Gorringe, L.I. Irons, A. Robinson.
Immune responses in humans and animals to meningococcal transferrin-binding proteins: Implications for vaccine design.
Infect Immun, 62 (1994), pp. 2984-2990
[21.]
R.K. Gupta, G.R. Siber.
Adjuvants for human vaccines current status, problems and future prospects.
Vaccine, 13 (1995), pp. 1263-1276
[22.]
J.A. Gomez, E. Hernandez, M.T. Criado, C.M. Ferreiros.
Effect of adjuvant in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of Neisseria meningitidis.
Vaccine, 16 (1998), pp. 1633-1639
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.eimc.2022.01.016
No mostrar más